Second, the off-label adoption pattern that the longevity reframing will inevitably accelerate is going to produce the next wave of monitoring, dosing, and selection problems, patients without obesity or diabetes do not have the diagnostic anchors (BMI, A1c, insulin resistance markers) that frame the on-label conversation, and the clinical infrastructure for managing GLP-1 therapy in metabolically healthy users is, charitably described, thin
Social media is full of discussions about weight-loss injections, dramatic transformations
Ozempic for Medical Weight Loss: How It Differs from Insulin Ozempic is a medication used to aid in medical weight loss
Conversely, sedentary patients or those engaging only in cardiovascular exercise without resistance components will experience greater muscle loss
Keep out of reach of children